Table 1 Estimated attributable fractions, deaths and registrations by cancer site in 2005 (deaths) and 2004 (registrations)

From: Occupational cancer burden in Great Britain

Cancer site Attributable fraction (%)
(95% confidence interval)
Attributable numbers
(95% confidence interval)
  ICD-10     Deaths (2005)a Registrations (2004)
  code Male Female Total Male Female Total Male Female Total
Bladder C67 7.1 (4.6, 9.7) 1.9 (1.3, 3.9) 5.3 (3.4, 7.7) 215 (139, 296) 30 (21, 62) 245 (159, 358) 496 (321, 684) 54 (37, 110) 550 (357, 795)
Bone C40–C41 0.04 0.01 0.02 0 0 0 0 0 0
Brain C70–C72 0.5 (0.1, 1.1) 0.1 (0, 0.2) 0.3 (0.0, 0.7) 10 (1, 20) 1 (0, 3) 11 (1, 23) 12 (1, 25) 2 (0, 4) 14 (1, 28)
Breast C50   4.6 (3.3, 6.0) 4.6 (3.3, 6.0)   555 (397, 727) 555 (397, 727)   1969 (1407, 2579) 1969 (1407, 2579)
Cervix C53   0.7 (0.0, 2.1) 0.7 (0.0, 2.1)   7 (0, 22) 7 (0, 22)   18 (1, 56) 18 (1, 56)
Kidney C64–C66, C68 0.04 (0, 0.16) 0.04 (0, 0.14) 0.04 (0, 0.15) 1 (0, 3) 1 (0, 2) 1 (0, 5) 2 (0, 7) 1 (0, 4) 3 (0, 10)
Larynx C32 2.9 (1.4, 5.7) 1.6 (0.6, 3.5) 2.6 (1.2, 5.2) 17 (8, 34) 3 (1, 6) 20 (9, 40) 50 (24, 99) 6 (2, 13) 56 (26, 112)
Leukaemiaa C91–C95 0.9 (0.2, 3.5) 0.5 (0.1, 4.5) 0.7 (0.1, 4.5) 18 (4, 71) 5 (1, 49) 23 (5, 120) 30 (7, 118) 9 (1, 80) 38 (8, 198)
Liver C22 0.2 (0.1, 0.3) 0.1 (0.1, 0.2) 0.2 (0.1, 0.3) 4 (2, 6) 2 (1, 2) 5 (3, 8) 4 (2, 6) 1 (1, 2) 5 (3, 8)
Lung C33–C34 21.1 (19.2, 24.7) 5.3 (4.3, 6.9) 14.5 (13.0, 17.2) 4020 (3659, 4696) 725 (592, 946) 4745 (4251, 5643) 4627 (4212, 5406) 815 (666, 1063) 5442 (4877, 6469)
LH C81–C96 0.004 (0, 0.014) 0.002 (0, 0.007) 0.003 (0, 0.011) 0 (0, 1) 0 (0, 0) 0 (0, 1) 0 (0, 1) 0 (0, 0) 1 (0, 2)
Melanoma (eye) C69 2.9 (0.6, 6.6) 0.4 (0.1, 1.0) 1.6 (0.3, 3.6) 1 (0, 3) 0 (0, 0) 1 (0, 3) 6 (1, 13) 1 (0, 2) 6 (1, 15)
Mesothelioma C45 97.0 (96.0, 98.0)b 82.5 (75.0, 90.0)b 94.9 (93.0, 96.9)b 1699 (1681, 1717) 238 (216, 260) 1937 (1898, 1976) 1699 (1681, 1717)c 238 (216, 260)c 1937 (1898, 1976)c
MM C90 0.4 (0, 1.0) 0.1 (0, 0.3) 0.3 (0, 0.7) 5 (0, 10) 1 (0, 2) 6 (0, 12) 8 (0, 18) 2 (0, 3) 10 (0, 21)
Nasopharynx C11 10.8 (2.3, 47.9) 2.4 (0.6, 6.8) 8.0 (1.8, 34.3) 7 (2, 31) 1 (0, 2) 8 (2, 33) 14 (3, 61) 1 (0, 4) 15 (3, 65)
NHL C82–C85 2.1 (0, 6.9) 1.1 (0.1, 2.9) 1.7 (0, 5.4) 43 (0, 138) 14 (1, 37) 57 (1, 176) 102 (0, 328) 39 (3, 101) 140 (3, 430)
NMSCd C44 6.9 (1.3, 15.0) 1.1 (0.0, 2.9) 4.5 (0.8, 9.9) 20 (4, 44) 2 (0, 6) 23 (4, 50) 2513 (478, 5447) 349 (0, 899) 2862 (478, 6346)
Oesophagus C15 3.3 (1.5, 7.5) 1.1 (0.3, 2.8) 2.5 (1.1, 5.9) 156 (70, 358) 28 (8, 70) 184 (78, 429) 159 (71, 365) 29 (9, 74) 188 (80, 439)
Ovary C56   0.5 (0, 1.2) 0.5 (0, 1.2)   23 (0, 52) 23 (0, 52)   33 (0, 76) 33 (0, 76)
Pancreas C25 0.02 (0, 0.07) 0.01 (0, 0.04) 0.01 (0, 0.05) 1 (0, 2) 0 (0, 1) 1 (0, 4) 1 (0, 2) 0 (0, 1) 1 (0, 4)
Sinonasal C30–C31 43.3 (27.3, 74.0) 19.8 (14.4, 31.6) 32.7 (21.5, 54.8) 27 (17, 47) 10 (8, 16) 38 (25, 63) 95 (60, 162) 31 (23, 50) 126 (83, 212)
STS C49 3.4 (0, 11.4) 1.1 (0, 3.8) 2.4 (0, 8.1) 11 (0, 36) 3 (0, 9) 13 (0, 45) 22 (0, 75) 4 (0, 15) 27 (0, 90)
Stomach C16 3.0 (1.5, 5.1) 0.3 (0.1, 0.5) 1.9 (1.0, 3.4) 101 (52, 176) 6 (3, 11) 108 (55, 187) 149 (77, 258) 9 (4, 15) 157 (81, 274)
Thyroid C73 0.12 0.02 0.05 0 0 0 0 0 1
Total: C00–C97          
Based on deaths   8.2 (7.2, 9.9) 2.3 (1.7, 3.2) 5.3 (4.6, 6.6) 6355 (5640, 7690) 1655 (1249, 2287) 8010 (6888, 9977)    
Based on registrations   5.7 (4.0, 8.4) 2.1 (1.4, 3.2) 4.0 (2.7, 5.9)     9988 (6938, 14,794) 3611 (2370, 5412) 13,598 (9308, 20,206)
Total cancers in GB in ages 15+      77,912 72,212 150,124 175,399 168,184 343,583
  1. Abbreviations: GB=Great Britain; ICD=International Classification of Diseases; NHL=non-Hodgkin's lymphoma; NMSC=non-melanoma skin cancer; STS=soft-tissue sarcoma.
  2. a Attributable fraction applicable to all leukaemias.
  3. b Includes cases described as due to paraoccupational or environmental exposure to asbestos.
  4. c Taken as equal to attributable deaths for this short survival cancer.
  5. d Based on registrations.
  6. Confidence intervals (CIs) were not estimated for bone and thyroid cancers, and other cancers attributed to ionising radiation, as CI estimates are not yet available for the excess relative risk models used (refer UNSCEAR report).